The tumour marker CDKN2A, with more than 23-fold higher expression in CIN3 versus normal biopsies, is a well-established immunohistochemical marker for grading of CIN1, CIN2, and CIN3 (32). The gene discussed is CDKN2A; the disease is neoplasm.